These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24505354)

  • 1. Quantitative methylation level of the EPHX1 promoter in peripheral blood DNA is associated with polycystic ovary syndrome.
    Sang Q; Li X; Wang H; Wang H; Zhang S; Feng R; Xu Y; Li Q; Zhao X; Xing Q; Jin L; He L; Wang L
    PLoS One; 2014; 9(2):e88013. PubMed ID: 24505354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of follistatin (FST) promoter methylation in peripheral blood of patients with polycystic ovary syndrome.
    Sang Q; Zhang S; Zou S; Wang H; Feng R; Li Q; Jin L; He L; Xing Q; Wang L
    Reprod Biomed Online; 2013 Feb; 26(2):157-63. PubMed ID: 23265961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.
    Horning AM; Awe JA; Wang CM; Liu J; Lai Z; Wang VY; Jadhav RR; Louie AD; Lin CL; Kroczak T; Chen Y; Jin VX; Abboud-Werner SL; Leach RJ; Hernandez J; Thompson IM; Saranchuk J; Drachenberg D; Chen CL; Mai S; Huang TH
    Prostate; 2015 Nov; 75(15):1790-801. PubMed ID: 26332453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomethylation of the LH/choriogonadotropin receptor promoter region is a potential mechanism underlying susceptibility to polycystic ovary syndrome.
    Wang P; Zhao H; Li T; Zhang W; Wu K; Li M; Bian Y; Liu H; Ning Y; Li G; Chen ZJ
    Endocrinology; 2014 Apr; 155(4):1445-52. PubMed ID: 24527662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell.
    Xu J; Bao X; Peng Z; Wang L; Du L; Niu W; Sun Y
    Oncotarget; 2016 May; 7(19):27899-909. PubMed ID: 27056885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between insulin resistance and CpG island methylation of LMNA gene in polycystic ovary syndrome.
    Ting W; Yanyan Q; Jian H; Keqin H; Duan M
    Cell Biochem Biophys; 2013; 67(3):1041-7. PubMed ID: 23605101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINE1 CpG-DNA Hypomethylation in Granulosa Cells and Blood Leukocytes Is Associated With PCOS and Related Traits.
    Sagvekar P; Mangoli V; Desai S; Patil A; Mukherjee S
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1396-1405. PubMed ID: 28324041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different EPHX1 methylation levels in promoter area between carbamazepine-resistant epilepsy group and carbamazepine-sensitive epilepsy group in Chinese population.
    Lv Y; Zheng X; Shi M; Wang Z; Cui L
    BMC Neurol; 2019 Jun; 19(1):114. PubMed ID: 31164100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsomal epoxide hydrolase (EPHX1) polymorphisms are associated with aberrant promoter methylation of ERCC3 and hematotoxicity in benzene-exposed workers.
    Xing C; Chen Q; Li G; Zhang L; Zheng M; Zou Z; Hou L; Wang QF; Liu X; Guo X
    Environ Mol Mutagen; 2013 Jul; 54(6):397-405. PubMed ID: 23797950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [(TTTTA), polymorphism in the promoter of the CYP11A1 gene in the pathogenesis of polycystic ovary syndrome].
    Prazáková S; Vanková M; Bradnová O; Lukásová P; Vcelák J; Dvoráková K; Vondra K; Vrbíková J; Bendlová B
    Cas Lek Cesk; 2010; 149(11):520-5. PubMed ID: 21391350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomethylation of specific CpG sites in the promoter region of steroidogeneic genes (GATA6 and StAR) in prenatally androgenized rats.
    Salehi Jahromi M; Hill JW; Ramezani Tehrani F; Zadeh-Vakili A
    Life Sci; 2018 Aug; 207():105-109. PubMed ID: 29859221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome.
    Yu YY; Sun CX; Liu YK; Li Y; Wang L; Zhang W
    Fertil Steril; 2015 Jul; 104(1):145-53.e6. PubMed ID: 25956362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylome profiling of granulosa cells reveals altered methylation in genes regulating vital ovarian functions in polycystic ovary syndrome.
    Sagvekar P; Kumar P; Mangoli V; Desai S; Mukherjee S
    Clin Epigenetics; 2019 Apr; 11(1):61. PubMed ID: 30975191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic DNA methylation in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture.
    Cui P; Ma T; Tamadon A; Han S; Li B; Chen Z; An X; Shao LR; Wang Y; Feng Y
    Exp Physiol; 2018 Dec; 103(12):1618-1632. PubMed ID: 30204276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome.
    Jiang LL; Xie JK; Cui JQ; Wei D; Yin BL; Zhang YN; Chen YH; Han X; Wang Q; Zhang CL
    Medicine (Baltimore); 2017 Jan; 96(2):e5768. PubMed ID: 28079802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal expression of uncoupling protein-2 correlates with CYP11A1 expression in polycystic ovary syndrome.
    Liu Y; Jiang H; He LY; Huang WJ; He XY; Xing FQ
    Reprod Fertil Dev; 2011; 23(4):520-6. PubMed ID: 21557918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation of the GC box in the promoter region mediates isolation rearing-induced suppression of srd5a1 transcription in the prefrontal cortex.
    Araki R; Nishida S; Hiraki Y; Matsumoto K; Yabe T
    Neurosci Lett; 2015 Oct; 606():135-9. PubMed ID: 26314512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of an adverse metabolic phenotype in polycystic ovary syndrome: the impact of the leukocyte methylation of PPARGC1A promoter.
    Zhao H; Zhao Y; Ren Y; Li M; Li T; Li R; Yu Y; Qiao J
    Fertil Steril; 2017 Feb; 107(2):467-474.e5. PubMed ID: 27889100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of genetic variants in the two isoforms of 5α-reductase, SRD5A1 and SRD5A2, in lean patients with polycystic ovary syndrome.
    Graupp M; Wehr E; Schweighofer N; Pieber TR; Obermayer-Pietsch B
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):175-9. PubMed ID: 21530059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome.
    Nilsson E; Benrick A; Kokosar M; Krook A; Lindgren E; Källman T; Martis MM; Højlund K; Ling C; Stener-Victorin E
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4465-4477. PubMed ID: 30113663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.